CUREXO, INC. Q3 operating loss of KRW 1.9 billion on KRW 14.7 billion in sales, turning to a loss
AI summary · Not investment advice
Curexo sold KRW 14.7 billion in the third quarter and lost KRW 1.9 billion from its main business, turning from profit to loss versus a year earlier and the prior quarter.
Operating profit · 3 months
KRW -1.9 billion
Key facts
- Revenue (3 months)
- KRW 14.7 billion
- Net income (3 months)
- KRW -3.4 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 17.2 billion
- Revenue (year to date)
- KRW 54.5 billion
- Operating profit (prior-year 3 months)
- KRW 341.2 million
- Operating profit (year to date)
- KRW -352.0 million
- Net income (prior-year 3 months)
- KRW 823.3 million
- Net income (year to date)
- KRW -407.6 million
Commentary
AI commentary · Not investment advice
What happened
Curexo reported its consolidated results for the 3rd quarter of 2026. Sales for the latest 3 months were KRW 14.75 billion. That is down 14.4% from the same period a year earlier and down 37.6% from the previous quarter. Cumulative sales this year are KRW 54.46 billion.
In the company's terms
Operating profit (money earned from the core business) for the latest 3 months was a loss of KRW 1.88 billion. A year earlier, the same period showed a profit of KRW 0.34 billion. It turned from profit to loss, and also turned to a loss compared with the previous quarter. Cumulative operating profit this year is a loss of KRW 0.35 billion.
What changes for shareholders
Net income (final profit after taxes and other items) for the latest 3 months was a loss of KRW 3.35 billion. A year earlier, the same period showed a profit of KRW 0.82 billion. Cumulative net income this year is a loss of KRW 0.41 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
C